Выживаемость больных диссеминированным раком почки после комбинированного лечения

Аннотация

The basis of this research were the results of examination and treatment of 170 patients with renal cell carcinoma addressed to the Samarkand Regional Oncology Center in the period from 2000 to 2012. From 68 patients in 27 (39.7%) the metastases were located in lungs, 4 (5.9%) – in liver, 9 (13.2%) - a skeletal bones, 6 (8.8% ) - in soft tissues, and in the ipsilateral adrenal gland, the pituitary gland, a pleura, the brain the me-tastases were determined with 1 (1,5%) accordingly, however in 18 (26.5%) - in two or more organs (lung, liver, skeletal bone, soft tissues). Defeat retroperitoneal lymph node in patients with metastases to one or more organs was observed in 24 cases (35.3%). In patients with primary generalized forms of renal cell can-cer metastasis can be located anywhere in the body and tissues, but most often they are found in the lungs, and make up about 40% of all metastases. The worst survival rates after treatment are observed in patients with metastases in two or more organs, as well as in patients with liver metastases. Indicators 5-year survival rate among patients with liver metastases totaled -7.9%, 33.5% in the bones of the skeleton. No patient with metastasis to the lungs, as well as the defeat of two or more organs have not lived up to the 5-year period of observation.